dabrafenib (tafinlar) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$32.0656 - $47.9235

VA Big4

$49.7393 - $63.9036

VA FSS

$70.4188 - $90.7523

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
dabrafenib mesylate 50 mg (CAPSULE) $32.0656 AUS PBS generic
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    dabrafenib mesylate 50 mg (CAPSULE) $49.7393 VA Big4
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Corporation
    dabrafenib mesylate 50 mg (CAPSULE) $70.4188 VA FSS
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Corporation
    dabrafenib mesylate 75 mg (CAPSULE) $47.9235 AUS PBS generic
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    dabrafenib mesylate 75 mg (CAPSULE) $63.9036 VA Big4
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Corporation
    dabrafenib mesylate 75 mg (CAPSULE) $90.7523 VA FSS
  • Tafinlar (120)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue